Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- Resource Type
- Source
- Dipòsit Digital de la UB
Universidad de Barcelona
BASE-Bielefeld Academic Search Engine
The New England journal of medicine
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP - Subject
0301 basic medicine Male Esclerosi múltiple Adult Antibodies, Monoclonal, Humanized Antigens, CD20 B-Lymphocytes Brain Disease Progression Female Humans Immunologic Factors Infusions, Intravenous Interferon-beta Magnetic Resonance Imaging Middle Aged Multiple Sclerosis, Relapsing-Remitting Recurrence Medicine (all) Relapsing-Remitting Gastroenterology Medicina Clínica [Ciências Médicas] law.invention 0302 clinical medicine Immunologic Factor Randomized controlled trial law Monoclonal Clinical endpoint Infusions, Intravenou Immunologia Humanized Hazard ratio B-Lymphocyte General Medicine Settore MED/26 - Neurologia Intravenous Neurotieteet - Neurosciences medicine.drug Human medicine.medical_specialty Infusions Multiple Sclerosis Immunology Antibodies Multiple sclerosis 03 medical and health sciences Internal medicine medicine CD20 Antigens Ciências Médicas::Medicina Clínica business.industry Interferon beta-1a medicine.disease Confidence interval Ocrelizumab Interferon Beta-1a Relapsing Multiple Sclerosis 030104 developmental biology Monoclonal antibodies Human medicine business Anticossos monoclonals 030217 neurology & neurosurgery - Language
- ISSN
- 0028-4793